NASDAQ: FBIOFortress Biotech Inc Stock Ownership - Who owns Fortress Biotech?
Insider buying vs selling
Have Fortress Biotech Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Jin | Chief Financial Officer | 2025-04-01 | 5,000 | $1.22 | $6.08kBuy |
| David Jin | Chief Financial Officer | 2024-10-01 | 2,625 | $1.23 | $3.22kBuy |
| Lindsay A. Md Rosenwald | PRESIDENT CEO CHAIRMAN | 2024-09-23 | 763,359 | $1.84 | $1.40MBuy |
FBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when FBIO insiders and whales buy or sell their stock.
FBIO Shareholders
What type of owners hold Fortress Biotech Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Lindsay A. Md Rosenwald | 22.11% | 6,579,083 | $25.59M | Insider |
| Elliott Associates LP | 6.98% | 2,076,381 | $8.08M | Insider |
| Michael S. Weiss | 6.05% | 1,801,138 | $7.01M | Insider |
| Elliott International LP | 5.56% | 1,654,898 | $6.44M | Insider |
| David Jin | 4.19% | 1,245,893 | $4.85M | Insider |
| Summit Financial LLC | 3.41% | 1,015,844 | $3.95M | Institution |
| Vanguard Group Inc | 2.87% | 852,922 | $3.32M | Institution |
| George Avgerinos | 2.20% | 655,170 | $2.55M | Insider |
| Kestra Advisory Services LLC | 1.12% | 331,998 | $1.29M | Institution |
| Nantahala Capital Management LLC | 1.09% | 325,520 | $1.27M | Institution |
FBIO vs Biotech Stocks
Fortress Biotech Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.